logo BDSP

Base documentaire

  1. Cost effectiveness of intradermal vs. subcutaneous hepatitis B vaccination for the mentally hadicapped.

    Article - En anglais

    The currently available hepatitis B vaccine is being under utilized for reasons of cost and availability.

    To address this problem, we performed a recombinant hepatitis B vaccine trial comparing the currently recommended regimen of 10 mug subcutaneously (sc) in months 0, 1 and 6 with a more economical regimen of 2 mug intradermally (ID) in months 0, 1, 6. This trial assessed the immunogenicity of both regimens in 95 seronegative mentally handicapped patients.

    Mots-clés Pascal : Hepadnaviridae, Virus, Analyse coût efficacité, Vaccination, Vaccin, Virus hépatite B, Voie souscutanée, Psychiatrie, Handicap, Homme, Voie intradermique, Economie santé

    Mots-clés Pascal anglais : Hepadnaviridae, Virus, Cost efficiency analysis, Vaccination, Vaccine, Hepatitis B virus, Subcutaneous administration, Psychiatry, Handicap, Human

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 91-0541672

    Code Inist : 002A05B12. Création : 199406.